Universal Health Services shares are higher today as investors continue to re-rate the stock following a better-than-expected first-quarter print and management’s message that 2026 volume and earnings growth plans remain intact despite a weak respiratory season and winter storms that weighed on early-quarter demand.

The latest push appears tied to the company’s Q1 2026 earnings release and follow-through commentary that it still expects full-year adjusted admissions growth of about 2% to 3% versus 2025, with much of the recovery anticipated in the second half of 2026. That combination—near-term outperformance plus a maintained full-year framework—has supported incremental buying interest after prior volatility around guidance and volumes.

Attention now shifts to whether volumes and margins accelerate as the year progresses, particularly in behavioral health and acute care, and whether staffing and wage pressures remain manageable. Investors are also monitoring updates around UHS’s pending Talkspace acquisition and any additional detail the company shares ahead of or during its May 20, 2026 annual meeting.